|
|
|
|
http://www.fda.gov/cder/dmf/text/4Q2003ACTIVETYPE2TEXT.txt
LISINOPRIL CRUDE AS MFG IN COURBEVOIE AND HAM FRANCE 14537 19-Nov-99 FUJISAWA PHARMACEUTICAL CO LTD FK8453 DRUG SUBSTANCE AS MFG IN HYOGO AND OSAKA JAPAN 14538 09-Nov-99 SICOR DE MEXICO SA DE CV AMCINONIDE AS MFG IN LERMA MEXICO 14539 18-Nov-99 "UQUIFA ITALIA, S.P.A." CLINDAMYCIN HYDROCHLORIDE USP AS MFG IN MILAN ITALY 14540 18-Nov-99 DIOSYNTH BV TESTOSTERONE UNDECANOATE AS MFG IN...
|
|
|
050926 Omacor
Solvay Pharmaceuticals -- -- News -- Solvay and Pronova Biocare sign license agreement for Omacor® - This Site- All Sites -Welcome - - Home -Company- -Strategy- -Acquisitions- -Licensing and strategic alliances- -Mission, Vision, Values- -Organization- -Marketing and sales- -Research and Development- -Manufacturing- -Our corporate offices- -Part of Solvay- -History- -Facts...
|
|
|
bfw07182005.qxd page 2
author: RobbinsJ
|
|
|
Literature Request Form
Compounds RK82.1 Fast Facts - RTX-VMS Colums RK83.1 Instrument Innovations RK84 RTX-Oppesticides 2 RK85 Pinnacle II HPLC Columns RK86 Food Flavor and Fragarances RK87 HPLC Accessories RK88 RTX 35 Amine RK89 Guide to Preparing and Analyzing Semi-Volatile Organic Compounds RK90 Pharmaceutical in Review RK91 RTS-200 RK92.1 Sonic Debubbler RK93 Bonded Plot Columns RK94 Pinnacle II Amino...
author: Graeme Lewis
|
|
|
News Releases
Solvay Pharmaceuticals -- -- News -- Parkinson's: Solvay Pharmaceuticals moves SLV 308 compound into phase III clinical development - This Site- All Sites -Welcome - - Home -Company- -Strategy- -Acquisitions- -Licensing and strategic alliances- -Mission, Vision, Values- -Organization- -Marketing and sales- -Research and Development- -Manufacturing- -Our corporate offices- -Part of...
|
|
|
Influenza vaccines
Solvay Pharmaceuticals -- Products -- Other major products -- Influenza vaccines - This Site- All Sites -Welcome - - Home -Company- -Strategy- -Acquisitions- -Licensing and strategic alliances- -Mission, Vision, Values- -Organization- -Marketing and sales- -Research and Development- -Manufacturing- -Our corporate offices- -Part of Solvay- -History- -Facts and figures- -In the world- ...
|
|
|
TEVETEN
Solvay Pharmaceuticals -- Products -- Cardiology -- TEVETEN® (eprosartan [mesylate]) - This Site- All Sites -Welcome - - Home -Company- -Strategy- -Acquisitions- -Licensing and strategic alliances- -Mission, Vision, Values- -Organization- -Marketing and sales- -Research and Development- -Manufacturing- -Our corporate offices- -Part of Solvay- -History- -Facts and figures- -In...
|
|
|
Physiotens
Solvay Pharmaceuticals -- Products -- Cardiology -- PHYSIOTENS® (moxonidine) - This Site- All Sites -Welcome - - Home -Company- -Strategy- -Acquisitions- -Licensing and strategic alliances- -Mission, Vision, Values- -Organization- -Marketing and sales- -Research and Development- -Manufacturing- -Our corporate offices- -Part of Solvay- -History- -Facts and figures- -In the world-...
|
|
|
Product
Solvay Pharmaceuticals -- Products -- Cardiology -- OMACOR® (omega unsaturated fatty acids) - This Site- All Sites -Welcome - - Home -Company- -Strategy- -Acquisitions- -Licensing and strategic alliances- -Mission, Vision, Values- -Organization- -Marketing and sales- -Research and Development- -Manufacturing- -Our corporate offices- -Part of Solvay- -History- ...
|
|
|
Facts and figures
Solvay Pharmaceuticals -- Company -- Facts and figures - This Site- All Sites -Welcome - - Home -Company- -Strategy- -Acquisitions- -Licensing and strategic alliances- -Mission, Vision, Values- -Organization- -Marketing and sales- -Research and Development- -Manufacturing- -Our corporate offices- -Part of Solvay- -History- -Facts and figures- -In the world- -Solvay Pharmaceuticals US...
|
|
|
AMR101 / Derivatives - Amarin
REFERENCES- Matsumoto et al - Abstract from ISSFAL meeting in Cairns Australia, 2006 (available upon request form Amarin) – “Oral Administration of Eicosapentaenoic Acid Reduces and Stabilizes Atherosclerotic Lesions Through Lipid Lowering Independent Mechanism in APO E-Deficient Mice” Cawood et al - Abstract from ISSFAL meeting in Cairns Australia, 2006 ...
author: Webtrade Ltd. - http://www.webtrade.ie
|
|
|
AMR101 / Derivatives - Amarin
REFERENCES- Matsumoto et al - Abstract from ISSFAL meeting in Cairns Australia, 2006 (available upon request form Amarin) – “Oral Administration of Eicosapentaenoic Acid Reduces and Stabilizes Atherosclerotic Lesions Through Lipid Lowering Independent Mechanism in APO E-Deficient Mice” Cawood et al - Abstract from ISSFAL meeting in Cairns Australia, 2006 ...
author: Webtrade Ltd. - http://www.webtrade.ie
|
|
|
News Releases
Solvay Pharmaceuticals -- -- News -- Solvay Pharmaceuticals completes acquisition of Neopharma in Sweden - This Site- All Sites -Welcome - - Home -Company- -Strategy- -Acquisitions- -Licensing and strategic alliances- -Mission, Vision, Values- -Organization- -Marketing and sales- -Research and Development- -Manufacturing- -Our corporate offices- -Part of Solvay- -History- -Facts and...
|
|
|
News
Solvay Pharmaceuticals -- -- News -- Solvay Pharmaceuticals will supply Norway with special vaccines in the event of an influenza pandemic - This Site- All Sites -Welcome - - Home -Company- -Strategy- -Acquisitions- -Licensing and strategic alliances- -Mission, Vision, Values- -Organization- -Marketing and sales- -Research and Development- -Manufacturing- -Our corporate offices- ...
|
|
|
News Releases
Solvay Pharmaceuticals -- -- News -- Cetrorelix progresses to full development in Solvay Pharmaceuticals for the treatment of Endometriosis in women - This Site- All Sites -Welcome - - Home -Company- -Strategy- -Acquisitions- -Licensing and strategic alliances- -Mission, Vision, Values- -Organization- -Marketing and sales- -Research and Development- -Manufacturing- -Our corporate...
|
|
|
050630 Cilansetron
Solvay Pharmaceuticals -- -- News -- MHRA requests further information on Cilansetron - This Site- All Sites -Welcome - - Home -Company- -Strategy- -Acquisitions- -Licensing and strategic alliances- -Mission, Vision, Values- -Organization- -Marketing and sales- -Research and Development- -Manufacturing- -Our corporate offices- -Part of Solvay- -History- -Facts and figures- -In the...
|
|
|
050712 Fournier
Solvay Pharmaceuticals -- -- News -- Solvay finalizes agreement to buy Fournier Pharma - This Site- All Sites -Welcome - - Home -Company- -Strategy- -Acquisitions- -Licensing and strategic alliances- -Mission, Vision, Values- -Organization- -Marketing and sales- -Research and Development- -Manufacturing- -Our corporate offices- -Part of Solvay- -History- -Facts and figures- -In the...
|
|
|
News Releases
Solvay Pharmaceuticals -- -- News -- Solvay and Berna Biotech sign a license agreement for Aerugen® - This Site- All Sites -Welcome - - Home -Company- -Strategy- -Acquisitions- -Licensing and strategic alliances- -Mission, Vision, Values- -Organization- -Marketing and sales- -Research and Development- -Manufacturing- -Our corporate offices- -Part of Solvay- -History- -Facts and...
|
|
|
News Releases
Solvay Pharmaceuticals -- -- News -- Solvay Pharmaceuticals launches DUODOPA® in 12 new European countries - This Site- All Sites -Welcome - - Home -Company- -Strategy- -Acquisitions- -Licensing and strategic alliances- -Mission, Vision, Values- -Organization- -Marketing and sales- -Research and Development- -Manufacturing- -Our corporate offices- -Part of Solvay- -History- ...
|
|
|
News Releases
Solvay Pharmaceuticals -- -- News -- Solvay’s Fluvoxamine maleate is first drug approved for the treatment of social anxiety disorder in Japan - This Site- All Sites -Welcome - - Home -Company- -Strategy- -Acquisitions- -Licensing and strategic alliances- -Mission, Vision, Values- -Organization- -Marketing and sales- -Research and Development- -Manufacturing- -Our corporate...
|
|
|
Solvay and Berna Biotech sign a license agreement for Aerugen®
Solvay Pharmaceuticals -- -- Solvay and Berna Biotech sign a license agreement for Aerugen® - This Site- All Sites -Welcome - - Home -Company- -Strategy- -Acquisitions- -Licensing and strategic alliances- -Mission, Vision, Values- -Organization- -Marketing and sales- -Research and Development- -Manufacturing- -Our corporate offices- -Part of Solvay- -History- -Facts and figures-...
|
|
|
Solvay Pharmaceuticals launches DUODOPA® in 12 new European countries
Solvay Pharmaceuticals -- -- Solvay Pharmaceuticals launches DUODOPA® in 12 new European countries - This Site- All Sites -Welcome - - Home -Company- -Strategy- -Acquisitions- -Licensing and strategic alliances- -Mission, Vision, Values- -Organization- -Marketing and sales- -Research and Development- -Manufacturing- -Our corporate offices- -Part of Solvay- -History- -Facts and...
|
|
|
News Releases
Solvay Pharmaceuticals -- -- News -- Solvay completes acquisition of Fournier Pharma - This Site- All Sites -Welcome - - Home -Company- -Strategy- -Acquisitions- -Licensing and strategic alliances- -Mission, Vision, Values- -Organization- -Marketing and sales- -Research and Development- -Manufacturing- -Our corporate offices- -Part of Solvay- -History- -Facts and figures- -In the...
|
|
|
Go to US site
Solvay Pharmaceuticals -- -- Solvay worldwide -- Go to US site - This Site- All Sites -Welcome - - Home -Company- -Strategy- -Acquisitions- -Licensing and strategic alliances- -Mission, Vision, Values- -Organization- -Marketing and sales- -Research and Development- -Manufacturing- -Our corporate offices- -Part of Solvay- -History- -Facts and figures- -In the world- -Solvay...
|
|
|
Solvay worldwide
Solvay Pharmaceuticals -- -- Solvay worldwide - This Site- All Sites -Welcome - - Home -Company- -Strategy- -Acquisitions- -Licensing and strategic alliances- -Mission, Vision, Values- -Organization- -Marketing and sales- -Research and Development- -Manufacturing- -Our corporate offices- -Part of Solvay- -History- -Facts and figures- -In the world- -Solvay Pharmaceuticals US- ...
|
